Has Hoda Elzawahry, MD received payments from drug or device companies?

Yes. Drug and device makers reported $100,681 in general payments to Hoda Elzawahry, MD across 289 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hoda Elzawahry, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hoda Elzawahry, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hoda Elzawahry, MD

Neurology · Panama City, FLNPI 1972791002

Payments from drug & device makers

$100,681in general payments, 2019–2025

Across 289 payments — averaging $348.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$97K
Argenx US, Inc.$430
Amgen$404
Novartis$315
Lilly USA, LLC$197
Lundbeck LLC$178
plus $2K from 39 others

What the payments were for

Speaking & faculty fees$91,57091%
Travel & lodging$4,5184%
Food & beverage$4,5935%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	117	$97,162
Argenx US, Inc.	4	$430
Amgen(2 entities)	21	$404
Novartis	24	$315
Lilly USA, LLC	5	$197
Lundbeck LLC	7	$178
Biogen	11	$172
Sunovion Pharmaceuticals Inc.	9	$145
AstraZeneca	8	$138
EMD Serono, Inc.	9	$129
Medtronic	3	$129
Greenwich Biosciences, Inc.	1	$127
Supernus Pharmaceuticals, Inc.	13	$120
Jazz Pharmaceuticals Inc.	6	$105
Teva Pharmaceuticals USA, Inc.	3	$86
MDD US Operations, LLC	6	$78
UCB, Inc.	3	$64
SK Life Science, Inc.	3	$60
Genentech USA, Inc.	3	$58
Octapharma USA, Inc.	2	$44
Livanova USA, Inc.	2	$38
Sanofi	2	$34
CSL Behring	1	$33
ANI Pharmaceuticals, Inc.	1	$32
Boston Scientific	2	$32
Zyla Life Sciences, Inc.	2	$30
Biodelivery Sciences International, Inc.	2	$27
Merz North America, Inc.	2	$25
Abbott	1	$25
Tanabe Pharma America, Inc.	1	$24
Adamas Pharmaceuticals, Inc.	1	$23
Harmony Biosciences LLC	1	$23
TG Therapeutics, Inc.	1	$23
GE HealthCare	1	$20
Mallinckrodt Enterprises LLC	1	$18
Mallinckrodt Hospital Products Inc.	1	$18
Amneal Pharmaceuticals LLC	1	$16
Johnson & Johnson	1	$14
Pfizer	1	$13
Acadia Pharmaceuticals Inc	1	$12
Biohaven Pharmaceuticals, Inc.	1	$12
Upsher-smith Laboratories LLC	1	$12
Kyowa Kirin, Inc.	1	$12
Avanir Pharmaceuticals, Inc.	1	$11
Life Molecular Imaging Ltd	1	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$100,681 in reported general payments places this provider in the 85th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024

$186,124

Medicare patients

656

Services billed

2,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	477	$13,725
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	279	$10,604
Fentanyl	41	$6,692
Xtampza ErOxycodone Myristate	13	$5,405
Morphine Sulfate ErMorphine Sulfate	43	$1,400
Oxycodone Hcl	57	$1,290
Pregabalin	33	$575
Modafinil	13	$417
Methadone Hcl	13	$356
Morphine Sulfate	14	$327
Tramadol Hcl	21	$325
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	12	$247
Levetiracetam	12	$236
Clonazepam	16	$142
Alprazolam	16	$98

Paid to pharmacies, not to this prescriber.

Other neurology in Panama City

Mark GoldsteinAtlantis$36.1M
Derrick RobertsonTampa$27.6M
Beth SafirsteinHallandale Beach$25.7M
Michael PfefferMiami$24.5M
Mark BrodyDelray Beach$20.5M
Paayal PatelWest Palm Beach$17.3M
Wendy BondFort Myers$14.7M
William HoneycuttMaitland$14.1M
Julie SchwartzbardAventura$13.6M
Rekha GandhiWinter Park$13.4M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →